L ymphogranuloma venereum (LGV) is a sexually transmitted infection (STI)
caused by Chlamydia trachomatis serotypes L1, L2 and L3. Unlike other serotypes (A to K), those that cause LGV are invasive and preferentially target lymph tissue.
LGV can be transmitted through vaginal, anal or oral sexual contact and can be prevented through the use of condoms or other barrier methods.
LGV infection begins with a small, painless lesion (which may go unnoticed) and can progress to painful enlargement of local lymph nodes, which may coalesce to form a bubo. 1 If the infection is left untreated, lymphatic obstruction may result, which can lead to serious complications, such as destruction of the genitals or rectum (including rectal stricture), and can uncommonly lead to meningoencephalitis, hepatitis and death. As with other STIs, the presence of LGV increases the risk for acquisition and transmission of HIV infection, other STIs and other conditions caused by bloodborne pathogens, such as hepatitis C.
Until recently, LGV was rare in industrialized countries, although it is endemic in parts of Africa, Asia, South America and the Caribbean. 2 However, cases in men having sex with men have been reported recently in Europe (starting in 2003 in the Netherlands, and additional cases being reported from Belgium, France, Germany, Sweden and Britain); cases have also been reported recently from the United States. These cases have been associated with concurrent HIV infection and hepatitis C, sex parties and higher-risk sexual activities (e.g., "fisting"). (Fig. 1) .
Epidemiologic data were available for 19 of the cases ( Table 1 ). The cases appear to be unlinked. All 19 cases were among men. Proctitis and inguinal lymphadenopathy were the most common presenting symptoms. Of the 8 patients concurrently infected with HIV, 3 also had hepatitis C; for only 1 of these 3 men was historical information available on behaviour placing the patient at increased risk of hepatitis C (sharing injection drug equipment, fisting and rectal use of methamphetamine in the 60 days before interview).
Of the 19 men, 12 reported having had sexual contact in the 60 days before their interview, 10 with male partners only (1-16 partners) and 1 with female partners only (2 partners); the remaining patient did not disclose partner information. Most often (in 6 [86%] of the 7 cases for which this information was available), sexual contact occurred in a private residence; bathhouse contact was reported by 4 men (33% of the 12) and finding partners on the Internet by 5 men (42% of the 12). None of the men reported having a sexual partner with known LGV. Although 2 of the men reported having had sex while travelling within Canada in the 60 days before their interview, none reported having had sex while travelling outside of Canada in this time frame.
Controlling transmission
Efforts to control the transmission of LGV include prevention, early diagnosis and appro- 
